For many Americans, the weight-loss medications broadly referred to as GLP-1s are transforming the way they think and feel ...
A November 2025 Kaiser Family Foundation poll found that 1 in 8 U.S. adults have tried a GLP-1 medication for weight loss, ...
Ozempic maker's lawsuit, FDA enforcement could curtail sales of less expensive, compounded, versions of popular weight loss ...
Australian researchers warn GLP-1 weight-loss drugs may cause scurvy, the historic "pirate disease," due to poor nutrition and vitamin C deficiency risks.
Make sure the clinician knows what other medications you’re taking, and set up a real follow-up plan to adjust these ...
Emma Dyer says she collapsed on her bathroom floor and began vomiting blood after buying jabs online.
Drugmakers Novo Nordisk and Eli Lilly are battling it out in the GLP-1 weight loss market. The pill version of Novo Nordisk's ...
The recent withdrawal of Hims & Hers’ GLP-1 pill raises questions about the safety and effectiveness of compounded medications ...
Eli Lilly and Company announced in December that its next-generation weight loss drug retatrutide helped patients shed more pounds than any other similar weight-loss drug during a late-stage trial.
A public health expert explains how GLP-1 drugs have changed the way healthcare providers understand and treat obesity.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results